Evidence map›Paper›PMID 30957059›Full record

SynthesisBJS open2019

Systematic review of therapeutic nipple-sparing

R A Agha, Y Al Omran, G Wellstead, H Sagoo, I Barai, S Rajmohan, M R Borrelli, M Vella-Baldacchino, D P Orgill, J E Rusby

Abstract readComparative StudySystematic Review
In one paragraph

Synthesis in BJS open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

R A AghaDepartment of Plastic Surgery, Royal Free NHS Foundation Trust London UK.
Y Al OmranDepartment of Plastic Surgery University Hospitals of North Midlands Stoke-on-Trent UK.ORCID 0000-0002-5608-216X
G WellsteadEar, Nose and Throat Department, Norfolk and Norwich University Hospitals NHS Foundation Trust Norwich UK.
H SagooGKT School of Medical Education, King's College London London UK.
I BaraiImperial College School of Medicine London UK.
S RajmohanImperial College School of Medicine London UK.
M R BorrelliDivision of Plastic Surgery, Stanford University Stanford California USA.
M Vella-BaldacchinoDepartment of Orthopaedics, Oxford University Hospitals NHS Foundation Trust Oxford UK.
D P OrgillDivision of Plastic Surgery, Brigham and Women's Hospital Boston Massachusetts USA.
J E RusbyBreast Surgical Unit, The Royal Marsden NHS Foundation Trust Sutton UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The use of nipple-sparing mastectomy (NSM) is increasing, despite unproven oncological safety in the therapeutic setting. The aim of this systematic review was to determine the safety and efficacy of NSM compared with skin-sparing mastectomy (SSM). Methods: A literature search of all original studies including RCTs, cohort studies and case-control studies comparing women undergoing therapeutic NSM or SSM for breast cancer was undertaken. Primary outcomes were oncological outcomes; secondary outcomes were clinical, aesthetic, patient-reported and quality-of-life outcomes. Data analysis was undertaken to explore the relationship between NSM and SSM, and preselected outcomes. Heterogeneity was assessed using the Cochrane tests. Results: A total of 690 articles were identified, of which 14 were included. There was no statistically significant difference in 5-year disease-free survival and mortality for NSM and SSM groups, where data were available. Local recurrence rates were also similar for NSM and SSM (3·9 Conclusion: In carefully selected cases, NSM is a viable choice for women with breast cancer who need to have a mastectomy. More research is needed to help further refine which surgical approaches to NSM optimize outcomes.

Indexed as

Patient SelectionBreast NeoplasmsDisease-Free SurvivalEstheticsFemaleHumansMastectomy, SubcutaneousNipplesOrgan Sparing TreatmentsPatient Reported Outcome MeasuresQuality of Life

Identifiers

PMID30957059
PMCPMC6433323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.